Biotech company Biogen lowered its full-year profit forecast, citing higher costs related to its purchase of drug maker Reata Pharmaceuticals as well as the launch of its Alzheimer's drug.
Share:
More In Business
Dude, Where’s My Ranch? These Getaways Reinvent the Iconic Western Vacation
Did you know there's a big difference between a dude ranch and a working cattle ranch? Check out the new generation of ranches, and live out your cowboy dreams.
Spatial Computing Could Replace the Smartphone
CEO of Auki Labs Nils Pihl breaks down what spatial computing is and all of the possibilities for bringing computers into the real world.
The Fed’s Rate Cuts Will Be ‘Surgical’
Lara Rhame, FS Investments chief U.S. economist, discusses the recent market highs, how the job market is in a ‘good place,’ and why rates staying higher for longer might not be a bad thing.
Nvidia's Winning Streak Continues: Earnings Exceed Expectations
Expectations were high for Nvidia’s earnings — and they came in even higher. But when will the AI boom start to slow?
Google Suspends Gemini AI Chatbot From Generating Images of People
Researchers have found racial biases in AI models. Did Gemini over-correct itself?
Can De-Extinction Save the Planet? Colossal Wants to Try
Co-founder and CEO of Colossal Ben Lamm explains how the company is working to bring back extinct species and shares early details of the upcoming documentary from the ‘My Octopus Teacher’ filmmaker.
Only You Can Prevent Volkswagen Fires
Volkswagen is recalling hundreds of thousands of cars to fix a possible fuel leak that could start fires. Is your car affected?
Get Your Finances in Order With CBIZ
President and CEO of CBIZ Jerry Grisko breaks down the financial services company’s latest earnings results.
The Audio A.I. Company That Received a Nvidia Investment
Soundhound AI co-founder, president, and CEO Keyvan Mojaver discusses bringing its audio tools to cars and drive-thrus, plus why smaller companies may benefit from the A.I. boom.
